This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Japan

Dr. Steven Fakharzadeh, MD, PhD
Global Medical Affairs Leader Immunodermatology at Johnson & Johnson
Speaker

Profile

Steve Fakharzadeh, MD, PhD - joined Johnson & Johnson (J&J) in 2008, leading US Medical Affairs for Dermatology through 2016 before moving to the J&J Global organization to lead Global Medical Affairs for Dermatology.

Prior to joining Johnson & Johnson, Steve was on the faculty in the Department of Dermatology at the University of Pennsylvania, where he still maintains an appointment as Adjunct Professor of Dermatology.

Steve graduated from Cornell University with a Bachelor of Arts degree and earned his MD and PhD degrees from the University of Pennsylvania School of Medicine. He completed his internship in Internal Medicine at Barnes Hospital of Washington University and his residency training in Dermatology at the University of Pennsylvania.

Agenda Sessions

  • Program Update on Icotrokinra (JNJ-2113) in Psoriasis: The First-in-Class Investigational Targeted Oral Peptide Designed to Block the IL-23 Receptor

    1:45pm